Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Quofenix 300 mg powder for concentrate for solution for infusion {equilateral_black_triangle}

Active Ingredient:
delafloxacin meglumine
Company:  
A. Menarini Farmaceutica Internazionale SRL See contact details
ATC code: 
J01MA23
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) HCP Med Info
{arrow_left}
{arrow_right}
The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine.
{info_black}
Last updated on emc: 08 Jan 2024

{equilateral_black_triangle} This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information.

{pdf} View or print the patient leaflet as PDF
A. Menarini Farmaceutica Internazionale SRL
Company image
Address
Menarini House, Mercury Park, Wycombe Lane, Wooburn Green, Buckinghamshire, HP10 0HH
Telephone
0800 085 8678
Fax
+44 (0) 1628 856402
Medical Information e-mail
[email protected]
Medical Information Direct Line
0800 085 8678
Out of Hours Telephone
0800 085 8678